The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial

Cancer Prevention Research · Published 2026-06-24 · Available online 23 Jun 2026 · DOI 10.1158/1940-6207.capr-26-0044

Free full text

Authors (21)

Leigha Senter, Shelly Hovick, Rachel Notestine, Lauren Norden, Nadia Benny, Shannon Phillips, Ava Willoughby, Robert Pyatt, Doreen Agnese, Julie S. Mak, Allison DePersia, Sarah V. Colonna, Whitney F. Maxwell, Wendy Kohlmann, Erika L. Spaeth, Ora Gordon, Darcy Thull, Guy N. Brock, Amy Webb, Rachel M. Smith, Amanda Ewart Toland

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Senter, L., Hovick, S., Notestine, R., et al. (2026). The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial. Cancer Prevention Research. https://doi.org/10.1158/1940-6207.capr-26-0044

Related articles

• Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches · Cancer Prevention Research · 2026 · Same journal
• The Long and Winding Road toward Prevention of Estrogen Receptor–Negative and BRCA1-Associated Breast Cancer · Cancer Prevention Research · 2026 · Same journal
• Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis · Cancer Prevention Research · 2026 · Same journal
• Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk? · Cancer Prevention Research · 2026 · Same journal
• Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial · Cancer Prevention Research · 2026 · Same journal
• Editors’ Selections from Relevant Scientific Publications · Cancer Prevention Research · 2026 · Same journal
• Pattern-based p53 and p16 Immunohistochemistry as a Potential Alternative to Loss of Heterozygosity Testing for Progression Risk of Oral Epithelial Dysplasia · Cancer Prevention Research · 2025 · Same journal
• Editors’ Selections from Relevant Scientific Publications · Cancer Prevention Research · 2026 · Same journal
• Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer · Cancer Prevention Research · 2025 · Same journal
• Reprogramming the Course of Precancer with Targeted Therapeutic Intervention: Lessons from Interception in Gastric Preneoplasia · Cancer Prevention Research · 2025 · Same journal